Ballow M - Search Results

1

Reconstitution of Clq after bone marrow transplantation in patients with severe combined immunodeficiency.

Ballow M, Day NK, Biggar WD, Park BH, Yount WJ, Good RA. Ballow M, et al. Clin Immunol Immunopathol. 1973 Nov;2(1):28-35. doi: 10.1016/0090-1229(73)90033-0. Clin Immunol Immunopathol. 1973. PMID: 4272769 No abstract available.

2

Report of a patient with T-cell deficiency and normal B-cell function: a new immunodeficiency disease with response to transfer factor.

Ballow M, Good RA. Ballow M, et al. Cell Immunol. 1975 Oct;19(2):219-29. doi: 10.1016/0008-8749(75)90205-1. Cell Immunol. 1975. PMID: 1081434 No abstract available.

3

Depletion of complement during graft-versus-host reaction in a severe combined immunodeficiency patient after receiving a mismatched marrow transplant.

Ballow M, Day NK, Good RA. Ballow M, et al. Transplantation. 1973 Oct;16(4):380-2. doi: 10.1097/00007890-197310000-00019. Transplantation. 1973. PMID: 4147640 No abstract available.

4

Developmental aspects of complement components in the newborn. The presence of complement components and C3 proactivator (properdin factor B) in human colostrum.

Ballow M, Fang F, Good RA, Day NK. Ballow M, et al. Clin Exp Immunol. 1974 Oct;18(2):257-66. Clin Exp Immunol. 1974. PMID: 4478765 Free PMC article.

5

Complement in graft versus host disease: IL Depletion of complement components during a systemic graft versus host reaction in the rat (38499).

Ballow M, Good RA, Day NK. Ballow M, et al. Proc Soc Exp Biol Med. 1975 Jan;148(1):170-6. doi: 10.3181/00379727-148-38499. Proc Soc Exp Biol Med. 1975. PMID: 236566

6

Effect of cobra venom factor on the local GVH reaction. I. Partial characterization of a cytotoxic factor from cobra venom for rat lymphocytes.

Ballow M, Day NK, Good RA. Ballow M, et al. J Immunol. 1973 Feb;110(2):354-61. J Immunol. 1973. PMID: 4405319 No abstract available.

7

C1-bypass complement-activation pathway in patients with chronic urticaria and angio-oedema.

Ballow M, Ward GW Jr, Gershwin ME, Day NK. Ballow M, et al. Lancet. 1975 Aug 9;2(7928):248-50. doi: 10.1016/s0140-6736(75)90963-0. Lancet. 1975. PMID: 49798

8

Complete absence of the third component of complement in man.

Ballow M, Shira JE, Harden L, Yang SY, Day NK. Ballow M, et al. J Clin Invest. 1975 Sep;56(3):703-10. doi: 10.1172/JCI108141. J Clin Invest. 1975. PMID: 1159084 Free PMC article.

9

Effect of transfer factor therapy on mixed lymphocyte culture reactivity.

Dupont B, Ballow M, Hansen JA, Quick C, Yunis EJ, Good RA. Dupont B, et al. Among authors: ballow m. Proc Natl Acad Sci U S A. 1974 Mar;71(3):867-71. doi: 10.1073/pnas.71.3.867. Proc Natl Acad Sci U S A. 1974. PMID: 4274562 Free PMC article.

10

Autoimmune hemolytic anemia in Wiskott-Aldrich syndrome during treatment with transfer factor.

Ballow M, Dupont B, Good RA. Ballow M, et al. J Pediatr. 1973 Nov;83(5):772-80. doi: 10.1016/s0022-3476(73)80368-3. J Pediatr. 1973. PMID: 4742570 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209 results

Search Page

Filters